The Quantified Behavioural Test Plus (QbTest+) in adult ADHD

Nylander, Elin; Sparding, Timea; Floros, Orestis; Rydén, Eleonore; Landén, Mikael; Hansen, Stefan

doi:10.1080/19012276.2022.2036628

Cited by 1 publication

(2 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A naturalistic study by Nylander et al . aimed to map QbTest performance in a group of patients already diagnosed with ADHD investigated if those patients who missed their medication performed worse than those who took their prescribed medication at baseline and at a follow-up four years later [ 34 ]. Most patients were prescribed more than one add-on drug to their stimulant.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review

Gustafsson,

Hansen

2023

CPEMH

View full text Add to dashboard Cite

Introduction: Attention deficit hyperactivity disorder (ADHD) is considered one of the most common neurodevelopmental disorders in childhood and adolescence. Pharmacological treatment plays an important part in the therapy of the disorder and verifying the effectiveness of ADHD medication is essential throughout the course of treatment. QbTest is a computerized test, for which intended use is to provide healthcare professionals with objective measurements of hyperactivity, impulsivity, and inattention to aid in the clinical assessment of ADHD and the evaluation of treatment interventions. Methods: A systematic review of relevant articles was conducted for which QbTest was used for monitoring medication treatment response in ADHD. Literature published between 2004 and 2023 was appraised. Results: A total of 15 studies were included in the review. Thirteen articles involved subjects diagnosed with ADHD and two studies that were related to the disorder, which evaluated QbTest in medication treatment response. Changes in QbTest data such as Q-scores, effect size, or improvement/deterioration of QbTest variables were evaluated. A clinically relevant decrease in QbTest Q-scores was found in the majority of the studies when treated with any type of ADHD medication in therapeutic doses, both in comparison to placebo and when compared from baseline to endpoint treatment. Conclusion: QbTest can distinguish pharmacological treatment effects within hours of pharmacological titration and can be used for monitoring of long-term treatment of ADHD. A need for optimization and individualization of medication treatment response could be addressed with access to objective measures in ADHD management.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Most patients were prescribed more than one add-on drug to their stimulant. Patients who tested twice on QbTest performed significantly better on the follow-up test 4 years later compared with baseline test on all three cardinals (p<0.05) [ 34 ].…”

Section: Discussionmentioning

confidence: 99%

QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review

Gustafsson,

Hansen

2023

CPEMH

View full text Add to dashboard Cite

show abstract

The Quantified Behavioural Test Plus (QbTest+) in adult ADHD

Cited by 1 publication

References 49 publications

QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review

QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review

Contact Info

Product

Resources

About